From Metcalf to myeloproliferative neoplasms - a personal journey

Exp Hematol. 2022 Jan:105:2-9. doi: 10.1016/j.exphem.2021.10.004. Epub 2021 Oct 24.

Abstract

The human myeloproliferative neoplasms constitute a biologically fascinating group of chronic myeloid malignancies. This perspective outlines how a postdoctoral fellowship working in Don Metcalf's unit proved a formative and immensely enjoyable experience for my family and me. It laid the foundation for a subsequent body of work over three decades that revealed the genetic basis of these diseases, defined how these genetic alterations subvert normal hematopoiesis, altered clinical practice, and provided insights of broad biological relevance for cancer and cytokine signaling.

Publication types

  • Review

MeSH terms

  • Academies and Institutes
  • Animals
  • Calreticulin / genetics
  • Genetic Predisposition to Disease
  • Hematologic Neoplasms / diagnosis
  • Hematologic Neoplasms / genetics*
  • Hematologic Neoplasms / therapy
  • Hematopoiesis
  • Humans
  • Janus Kinase 2 / genetics
  • Mutation
  • Myeloproliferative Disorders / diagnosis
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / therapy
  • Prognosis

Substances

  • CALR protein, human
  • Calreticulin
  • JAK2 protein, human
  • Janus Kinase 2